Induction of apoptosis by 15d-PGJ2 via ROS formation: An alternative pathway without PPARγ activation in non-small cell lung carcinoma A549 cells

Prostaglandins and Other Lipid Mediators

Volumn 94, Issue 3-4, 2011, Pages 104-111

  Wang, Jun Jie ^a   Mak, Oi Tong ^a,b  

^a NATIONAL CHENG KUNG UNIVERSITY   (Taiwan)

^b University of Kang Ning   (Taiwan)

Author keywords

15 Deoxy 12,14 prostaglandin J2 (15d PGJ 2); Apoptosis; Oxidative stress; Quercetin

Indexed keywords

15 DEOXY DELTA12,14 PROSTAGLANDIN J2; 2 CHLORO 5 NITROBENZANILIDE; CASPASE 3; CASPASE 8; CASPASE 9; GLUTATHIONE; PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR GAMMA; PROTEIN KINASE B; QUERCETIN; REACTIVE OXYGEN METABOLITE;

APOPTOSIS; ARTICLE; CARCINOMA CELL; CELL VIABILITY; CONTROLLED STUDY; DRUG MECHANISM; ENZYME ACTIVATION; ENZYME ACTIVITY; FLOW CYTOMETRY; HUMAN; HUMAN CELL; LUNG NON SMALL CELL CANCER; PROTEIN EXPRESSION; RECEPTOR DOWN REGULATION;

APOPTOSIS; CARCINOMA, NON-SMALL-CELL LUNG; CASPASES; CELL LINE, TUMOR; GLUTATHIONE; HUMANS; LUNG NEOPLASMS; PPAR GAMMA; PROSTAGLANDIN D2; QUERCETIN; REACTIVE OXYGEN SPECIES; THIAZOLIDINEDIONES;

EID: 79954425623     PISSN: 10988823     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.prostaglandins.2011.01.004     Document Type: Article

References (41)

1. 2. Identification of products formed in vitro. J Biol Chem 1983;258:11713-8.
2. 2: the anti-inflammatory prostaglandin? Clin Immunol 2005;114:100-9.
3. Straus DS, Glass CK. Cyclopentenone prostaglandins: new insights on biological activities and cellular targets. Med Res Rev 2001;21:185-210. (Pubitemid 32303994)
4. Cuzzocrea S, Wayman NS, Mazzon E, et al. The cyclopentenone prostaglandin 15-deoxy-delta(12,14)-prostaglandin J(2) attenuates the development of acute and chronic inflammation. Mol Pharmacol 2002;61:997-1007.
5. 2 for induction of human articular chondrocyte apoptosis in arthritis. J Biol Chem 2004;279:37939-50.
6. 2 is a ligand for the adipocyte determination factor PPAR gamma. Cell 1995;83:803-12.
7. Kliewer SA, Lenhard JM, Willson TM, Patel I, Morris DC, Lehmann JM. A prostaglandin J2 metabolite binds peroxisome proliferator-activated receptor gamma and promotes adipocyte differentiation. Cell 1995;83:813-9. (Pubitemid 3006325)
8. 2 as a potential endogenous regulator of redox-sensitive transcription factors. Biochem Pharmacol 2006;72:1516-28.
9. Ricote M, Li AC, Willson TM, Kelly CJ, Glass CK. The peroxisome proliferator-activated receptor-gamma is a negative regulator of macrophage activation. Nature 1998;391:79-82. (Pubitemid 28079218)
10. Lee Y, Huang TS, Yang ML, Huang LR, Chen CH, Lu FJ. Peroxisome proliferation, adipocyte determination and differentiation of C3H10T1/2 fibroblast cells induced by humic acid: induction of PPAR in diverse cells. J Cell Physiol 1999;179:218-25. (Pubitemid 29165150)
11. Allred CD, KilgoreMW.Selective activation of PPARgamma in breast, colon, and lung cancer cell lines. Mol Cell Endocrinol 2005;235:21-9. (Pubitemid 40615194)
12. Kim SH, Yoo CI, Kim HT, Park JY, Kwon CH, Kim YK. Activation of peroxisome proliferator-activated receptor-gamma (PPARgamma) induces cell death through MAPK-dependent mechanism in osteoblastic cells. Toxicol Appl Pharmacol 2007;215:198-207. (Pubitemid 44190007)
13. 2 induces apoptosis via JNK-mediated mitochondrial pathway in osteoblastic cells. Toxicology 2008;248:121-9.
14. Chinetti G, Griglio S, Antonucci M, et al. Activation of proliferator-activated receptors alpha and gamma induces apoptosis of human monocyte-derived macrophages. J Biol Chem 1998;273:25573-80. (Pubitemid 28475776)
15. Hashimoto K, Ethridge RT, Evers BM. Peroxisome proliferator-activated receptor gamma ligand inhibits cell growth and invasion of human pancreatic cancer cells. Int J Gastrointest Cancer 2002;32:7-22. (Pubitemid 36323098)
16. Keshamouni VG, Reddy RC, Arenberg DA, et al. Peroxisome proliferator activated receptor-gamma activation inhibits tumor progression in non-small cell lung cancer. Oncogene 2004;23:100-8. (Pubitemid 38142244)
17. Rumi MA, Sato H, Ishihara S, et al. Peroxisome proliferator-activated receptor gamma ligand-induced growth inhibition of human hepatocellular carcinoma. Br J Cancer 2001;84:1640-7. (Pubitemid 32612496)
18. Ishihara S, Rumi MA, Okuyama T, Kinoshita Y. Effect of prostaglandins on the regulation of tumor growth. Curr Med Chem Anticancer Agents 2004;4:379-87. (Pubitemid 38923330)
19. 2 on cell proliferation and apoptosis in ECV304 endothelial cells. Acta Pharmacol Sin 2004;25:47-53.
20. Chen YC, Shen SC, Tsai SH. Prostaglandin D(2) and J(2) induce apoptosis in human leukemia cells via activation of the caspase 3 cascade and production of reactive oxygen species. Biochim Biophys Acta 2005;1743:291-304.
21. 2 and ciglitazone induce human B lymphocyte and B cell lymphoma apoptosis by PPARgamma-independent mechanisms. J Immunol 2006;177:5068-76.
22. Zhang X, Young HA. PPAR and immune system - what do we know? Int Immunopharmacol 2002;2:1029-44.
23. Kim KY, Ahn JH, Cheon HG. Apoptotic action of peroxisome proliferator-activated receptor-gamma activation in human non-small cell lung cancer is mediated via proline oxidase-induced reactive oxygen species formation. Mol Pharmacol 2007;72:674-85.
24. Hempel SL, Buettner GR, O'Malley YQ, Wessels DA, Flaherty DM. Dihydrofluorescein diacetate is superior for detecting intracellular oxidants: comparison with 2′,7′-dichlorodihydrofluorescein diacetate, 5(and 6)-carboxy-2′,7′-dichlorodihydrofluorescein diacetate, and dihydrorhodamine 123. Free Radic Biol Med 1999;27:146-59.
25. Lehmann JM, Moore LB, Smith-Oliver TA, Wilkison WO, Willson TM, Kliewer SA. An antidiabetic thiazolidinedione is a high affinity ligand for peroxisome proliferator-activated receptor gamma (PPAR gamma). J Biol Chem 1995;270:12953-6.
26. Ward C, Dransfield I, Murray J, Farrow SN, Haslett C, Rossi AG. Prostaglandin D2 and its metabolites induce caspase-dependent granulocyte apoptosis that is mediated via inhibition of I kappa B alpha degradation using a peroxisome proliferator-activated receptor-gamma-independent mechanism. J Immunol 2002;168:6232-43. (Pubitemid 34620043)
27. 2 induces apoptosis by reactive oxygen species-mediated inactivation of Akt in leukemia and colorectal cancer cells and shows in vivo antitumor activity. Clin Cancer Res 2009;15(17):5414-25.
28. Eom JM, Seo MJ, Baek JY, et al. Alpha-eleostearic acid induces autophagy-dependent cell death through targeting AKT/mTOR and ERK1/2 signal together with the generation of reactive oxygen species. Biochem Biophys Res Commun 2010;391:903-8.
29. Cassidy PB, Edes K, Nelson CC, Parsawar K, Fitzpatrick FA, Moos PJ. Thioredoxin reductase is required for the inactivation of tumor suppressor p53 and for apoptosis induced by endogenous electrophiles. Carcinogenesis 2006;27:2538-49. (Pubitemid 44884113)
30. 2, is metabolized by HepG2 cells via conjugation with glutathione. Chem Res Toxicol 2007;20:1528-35.
31. 2 protects brain from ischemia-reperfusion injury. Arterioscler Thromb Vasc Biol 2006;26:481-7.
32. Chang JY, Bora PS, Bora NS. Prevention of oxidative stress-induced retinal pigment epithelial cell death by the PPARgamma agonists, 15-deoxy-delta 12,14-prostaglandin J(2). PPAR Res 2008;2008:720163.
33. Havsteen B. Flavonoids, a class of natural products of high pharmacological potency. Biochem Pharmacol 1983;32:1141-8. (Pubitemid 13135620)
34. Corvazier E, Maclouf J. Interference of some flavonoids and non-steroidal antiinflammatory drugs with oxidative metabolism of arachidonic acid by human platelets and neutrophils. Biochim Biophys Acta 1985;835:315-21. (Pubitemid 15066071)
35. 2-induced apoptosis via anti-oxidant activity and heme oxygenase 1 gene expression in macrophages. Biochem Pharmacol 2005;69:1839-51.
36. Di Carlo G, Mascolo N, Izzo AA, Capasso F. Flavonoids: old and new aspects of a class of natural therapeutic drugs. Life Sci 1999;65:337-53. (Pubitemid 29325278)
37. Kuo PC, Liu HF, Chao JI. Survivin and p53 modulate quercetin-induced cell growth inhibition and apoptosis in human lung carcinoma cells. J Biol Chem 2004;279:55875-85.
38. Tan WF, Lin LP, Li MH, et al. Quercetin, a dietary-derived flavonoid, possesses antiangiogenic potential. Eur J Pharmacol 2003;459:55-262.
39. Haghiac M, Walle T. Quercetin induces necrosis and apoptosis in SCC-9 oral cancer cells. Nutr Cancer 2005;53:220-31.
40. Robaszkiewicz A, Balcerczyk A, Bartosz G. Antioxidative and prooxidative effects of quercetin on A549 cells. Cell Biol Int 2007;31:1245-50. (Pubitemid 47030992)
41. Lee DH, Szczepanski M, Lee YJ. Role of Bax in quercetin-induced apoptosis in human prostate cancer cells. Biochem Pharmacol 2008;75:2345-55.